|
YIPF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.39009995023554E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78799974825949E-10 |
| Normal-vs-Stage2 |
1.680240E-02 |
| Normal-vs-Stage3 |
3.354000E-02 |
| Normal-vs-Stage4 |
2.596100E-02 |
| Stage1-vs-Stage2 |
1.175850E-01 |
| Stage1-vs-Stage3 |
7.300900E-03 |
| Stage1-vs-Stage4 |
6.326200E-01 |
| Stage2-vs-Stage3 |
5.746000E-01 |
| Stage2-vs-Stage4 |
6.171400E-01 |
| Stage3-vs-Stage4 |
3.215600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.37039995912392E-09 |
| Normal-vs-AfricanAmerican |
9.55690000026266E-07 |
| Normal-vs-Asian |
4.523700E-03 |
| Caucasian-vs-AfricanAmerican |
7.684600E-01 |
| Caucasian-vs-Asian |
9.404200E-01 |
| AfricanAmerican-vs-Asian |
8.692400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38059563781212E-11 |
| Normal-vs-Female |
1.872330E-02 |
| Male-vs-Female |
4.36910000001234E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.93429999999695E-05 |
| Normal-vs-Extreme_Weight |
1.23509980021197E-10 |
| Normal-vs-Obese |
4.37779999999943E-05 |
| Normal-vs-Extreme_Obese |
1.5771999999914E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.284550E-01 |
| Normal_Weight-vs-Obese |
4.686800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.661600E-01 |
| Extreme_Weight-vs-Obese |
4.635800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.028400E-01 |
| Obese-vs-Extreme_Obese |
2.042600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.498580E-01 |
| Normal-vs-Age(41-60Yrs) |
3.73779999951473E-07 |
| Normal-vs-Age(61-80Yrs) |
1.5446000034558E-10 |
| Normal-vs-Age(81-100Yrs) |
9.71870000032737E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.239800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.454830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.075560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.630100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.750300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.888800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.10753636764593E-12 |
| Normal-VS-Type2 PRCC |
3.777100E-04 |
| Normal-VS-KIRP CIMP |
8.697800E-01 |
| Normal-VS-Unclassified PRCC |
1.058860E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.217010E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.772100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.996900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.392600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.244800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.256580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.17579999975904E-07 |
| Normal-vs-N1 |
4.448500E-02 |
| Normal-vs-N2 |
7.273200E-01 |
| N0-vs-N1 |
1.141770E-01 |
| N0-vs-N2 |
1.958750E-01 |
| N1-vs-N2 |
6.528200E-01 |
|
|
